EFFECT OF QUERCETIN ON THE SYSTEMIC INFLAMMATORY RESPONSE AND METABOLIC ALTERATIONS IN REPETITIVE MILD TRAUMATIC BRAIN INJURY UNDER CHRONIC ALCOHOL INTOXICATION

Read full text Summarise with VIRAT
Authors: I.M. Adamovych, Heorhii Kostenko, O. Ye. Akimov, V.O. Kostenko
Cited by: 0
References: 25

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Repetitive mild traumatic brain injury (TBI) under chronic alcohol intoxication (CAI) represents a prevalent comorbid condition associated with neuroinflammation, metabolic disturbances, and an increased risk of chronic traumatic encephalopathy. The search for pharmacological agents capable of simultaneously mitigating neural tissue damage and correcting systemic metabolic dysregulation is of considerable scientific and clinical relevance. This study investigated the effects of quercetin on biomarkers of neural tissue injury, systemic inflammatory response parameters, and carbohydrate and lipid metabolism in rats subjected to repetitive mild TBI under CAI. The experiment was performed on Wistar rats divided into three groups: Group 1 (Control I) – intact animals; Group 2 – rats exposed to TBI combined with CAI (Control II); Group 3 – rats receiving an intraperitoneal water-soluble form of quercetin (Corvitin) at 100 mg/kg for 14 days following TBI with CAI. TBI was induced using a free-weight drop method (five sessions at 48-hour intervals), while CAI was modeled by administering 40% ethanol at 12 ml/kg for 14 days. Serum concentrations of neuron-specific enolase (NSE), calcium-binding protein S100B, tumor necrosis factor-alpha (TNF-α), interleukins (IL)-6 and IL-10, glucose, insulin, and lipid profile parameters were measured, and the HOMA-IR index was calculated. TBI combined with CAI resulted in marked neuroinflammation and systemic inflammatory response, as evidenced by significant elevations in neural tissue injury markers, increased serum levels of pro-inflammatory cytokines TNF-α and IL-6, and the development of insulin resistance and dyslipidemia. Administering quercetin led to significant reductions in serum NSE (61.9%), S100B (56.3%), TNF-α (40.8%), and IL-6 (42.0%), as well as a 187.5% increase in IL-10. Furthermore, compared with Group 2 values, the bioflavonoid reduced glucose by 30.5%, insulin by 68.7%, very low-density lipoproteins (VLDL) by 42.3%, triglycerides by 41.9%, and HOMA-IR by 78.4%. These findings indicate that quercetin exerts pronounced neuroprotective and anti-inflammatory effects under conditions of TBI combined with CAI, effectively lowering serum biomarkers of neural tissue injury and pro-inflammatory cytokines, while enhancing the anti-inflammatory cytokine IL-10. Moreover, quercetin efficiently restores metabolic homeostasis by normalising glycemia, improving insulin sensitivity, and reducing dyslipidemia.

Fields of Study & Subjects

Traumatic Brain Injury and Neurovascular Disturbances Traumatic Brain Injury Research Flavonoids in Medical Research

Publication details

Journal / source
Fìzìologìčnij žurnal
Volume
72
Issue
02
Pages
20–28
Publication date
24 March 2026
Language
EN